Think Brain Tumor
Minimally invasive, more effective treatments
When it comes to restoring quality of life, experience matters. Our surgeons have helped lead the way world-wide in advancing safe and effective keyhole and endoscopic brain tumor removal. ”Minimally invasive” is here today, every day at PNI. Ask our patients.
Clinical Trials & Novel Approaches
Our neuro-oncologists are at the forefront of applying brain tumor genomics to developing personalized treatments, including the evaluation of clinical trial eligibility. We provide targeted therapies and advanced treatment options patients may not have elsewhere.
Conditions We Treat:
There’s Always Time For a Second Opinion
If you or someone you care for have been recently diagnosed with a brain or skull base tumor (benign or malignant) there’s time for you to get another viewpoint. We’ll provide a rapid review of your medical records and imaging and give you our unique perspective on the optimal treatment pathway.
Get a Second Opinion
If you live in the United States outside Greater Los Angeles or are living abroad, our physicians can promptly review your imaging studies and other tests, and provide a recommendation on treatment options.Get a Second Opinion
Pacific Brain Tumor Center News, Healthy Living and Education
The Power of Immunotherapy
Our immune systems hold the power—the power, that is, to treat cancer. Composed of various types of cells, tissues, and organs, the immune system serves as more than the body’s main defense against foreign invaders such as bacteria and viruses. It also recognizes cancer cells…
PNI Founders’ Message 2021
Although our medical community continues to strain under the burden of COVID-19, there has been hope, determination and progress. Neurological diseases do not stop and neither have we at Pacific Neuroscience Institute.
Supporting Family Members, Friends and Caregivers After Loss
This article was published on U.S News and World report, December 11, 2020 For loved ones left behind during the pandemic, suffering may endure for years. AS I WRITE THIS, COVID-19 has taken the lives of nearly 300,000 Americans. Each death leaves behind a circle of…
Clinical Trials Round-Up: December 2020
New Studies Blue Earth Diagnostics FLC-219: (PDF): An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy (PURSUE) (NCT04410367) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A…